Hamburg, February 17: According to the U.S. researcher taking an aspirin two days a week significantly reduced breast cancer survivors’ risk of metastasis — cancer spread — and death.
Medpage Today reported on Tuesday that Dr. Michelle D. Holmes of the Channing Laboratory at Harvard and Brigham and Women’s Hospital in Boston, and colleagues found an aspirin at least two days a week significantly reduced breast cancer death risk by 64 percent to 71 percent.
The analysis included responses from 4,164 female registered nurses diagnosed with early stage breast cancer from 1976-2002 with follow-up through death or June 2006.
It was further added by Holmes that since the drug is discouraged during chemotherapy, aspirin use assessments in the first year after the breast cancer diagnosis was excluded.
The study further said that for the women who survived for more than a year after diagnosis, those who used aspirin more were less likely to subsequently die from breast cancer.
Journal of Clinical Oncology published the findings which according to it were “all the more notable because the Nurses’ Health Study did not find an association between aspirin use and breast cancer incidence.”
——-Agencies